Sector Watch: Healthcare - Mar 25 2019
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $108.32 +0.15 0.14% | XBI: $87.99 +0.13 0.15% | Updated Mar 25, 2019 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| NK NantKwest $132.1M |
1.67+0.41 8.8 M 24.6x |
33% | ||
| CRIS Curis $62.6M |
1.89+0.46 19.6 M 112.3x |
32% | ||
| CPRX52WH Catalyst Pharmaceuticals $538.4M |
5.24+1.22 13.1 M 9.7x |
30% | ||
| AXSM52WH Axsome Therapeutics $543.8M |
16.34+3.34 4.6 M 5.0x |
26% | ||
| CCXI ChemoCentryx $639.2M |
12.16+1.25 5.4 M 13.3x |
11% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| PTI52WL Proteostasis Therapeutics $66.9M |
1.31-2.76 27.7 M 23.0x |
-68% | ||
| REPH Recro Pharma $141.0M |
6.41-3.31 3.4 M 13.0x |
-34% | ||
| NEOS Neos Therapeutics $142.2M |
2.86-0.42 800.7 K 1.9x |
-13% | ||
| EOLS Evolus $576.6M |
21.14-2.87 1.7 M |
-12% | ||
| AKTX Akari Therapeutics $5.6B |
3.69-0.41 341.9 K |
-10% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants and Options in Support of NK?s Natural Killer Cell Strategic Vision Beyond Check Point Immunotherapy | Business Wire [businesswire.com]Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors Nasdaq:REPH [globenewswire.com]
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam [globenewswire.com]
Evolus Announces Publication of U.S. Phase III Pivotal Trial Results for Jeuveau? in Dermatologic Surgery - GlobeNewswire (0 visits) [globenewswire.com]
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update [globenewswire.com]
Evolus Reports Fourth Quarter and Full Year 2018 Results [globenewswire.com]
Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
